Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
Maria Sandu
In This Story LLY NVO Eli Lilly’s ( LLY ) and Novo Nordisk’s ( NVO ) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top. Suggested Reading The U.S. and China called a trade war truce. Here's what to know The Dow surges 1,000 points and the Nasdaq soars as the U.S. and China call a trade war truce Apple's brutal year keeps getting worse How Trump’s tariffs could make your iPhone cost $3,500 CC Share Subtitles Off English Share
din zilele anterioare